ASTRAZENECA FDA Approval NDA 022214

NDA 022214

ASTRAZENECA

FDA Drug Application

Application #022214

Documents

Review2010-03-04
Letter2008-12-11
Pediatric Medical Review1900-01-01
Pediatric Clinical Pharmacology Review1900-01-01
Pediatric Statistical Review1900-01-01
Pediatric Written Request1900-01-01

Application Sponsors

NDA 022214ASTRAZENECA

Marketing Status

Prescription001

Application Products

001TABLET; ORAL1MG2ARIMIDEXANASTROZOLE

FDA Submissions

TYPE 6; Type 6 - New Indication (no longer used)ORIG1AP2008-12-05PRIORITY

Submissions Property Types

ORIG1Null8

TE Codes

001PrescriptionTBD

CDER Filings

ASTRAZENECA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22214
            [companyName] => ASTRAZENECA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ARIMIDEX","activeIngredients":"ANASTROZOLE","strength":"1MG","dosageForm":"TABLET; ORAL","marketingStatus":"Prescription","te":"","rld":"TBD","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ARIMIDEX","submission":"ANASTROZOLE","actionType":"1MG","submissionClassification":"TABLET; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">TBD"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.